ATE246934T1 - Phosphoryliertes rekombinantes menschliches beta- kasein für die hemmung der anheftung von h. influenzae an menschlichen zellen - Google Patents

Phosphoryliertes rekombinantes menschliches beta- kasein für die hemmung der anheftung von h. influenzae an menschlichen zellen

Info

Publication number
ATE246934T1
ATE246934T1 AT96942738T AT96942738T ATE246934T1 AT E246934 T1 ATE246934 T1 AT E246934T1 AT 96942738 T AT96942738 T AT 96942738T AT 96942738 T AT96942738 T AT 96942738T AT E246934 T1 ATE246934 T1 AT E246934T1
Authority
AT
Austria
Prior art keywords
recombinant human
phosphorylated recombinant
influenzae
inhibiting
human beta
Prior art date
Application number
AT96942738T
Other languages
English (en)
Inventor
Pradip Mukerji
Jennifer Marie Thurmond
Lennart Hansson
Jennifer Harris Baxter
Robert George Hards
Amanda Eun-Yeong Leonard
Steven Neal Anderson
Linda Ann Regan
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE246934T1 publication Critical patent/ATE246934T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT96942738T 1995-11-06 1996-11-06 Phosphoryliertes rekombinantes menschliches beta- kasein für die hemmung der anheftung von h. influenzae an menschlichen zellen ATE246934T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55394195A 1995-11-06 1995-11-06
PCT/US1996/017971 WO1997026320A2 (en) 1995-11-06 1996-11-06 Product for inhibition of attachment of h. influenzae to human cells

Publications (1)

Publication Number Publication Date
ATE246934T1 true ATE246934T1 (de) 2003-08-15

Family

ID=24211413

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96942738T ATE246934T1 (de) 1995-11-06 1996-11-06 Phosphoryliertes rekombinantes menschliches beta- kasein für die hemmung der anheftung von h. influenzae an menschlichen zellen

Country Status (8)

Country Link
EP (1) EP0859629B1 (de)
JP (1) JP2000503319A (de)
AT (1) ATE246934T1 (de)
AU (1) AU1158197A (de)
CA (1) CA2234680A1 (de)
DE (1) DE69629487D1 (de)
MX (1) MX9803568A (de)
WO (1) WO1997026320A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
EP0862450A2 (de) * 1995-11-06 1998-09-09 Abbott Laboratories Verfahren zur hemmung der anheftung von h.influenzae an menschlichen zellen unter verwendung von phosphoryliertem recombinant menschlichen beta-casein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465109B (sv) * 1989-10-30 1991-07-29 Bengt Andersson Antibakteriell komposition
US5795611A (en) * 1989-12-20 1998-08-18 Slattery; Charles W. Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
JPH11500920A (ja) * 1995-02-27 1999-01-26 アボツト・ラボラトリーズ 修飾された組換えタンパク質を細菌系において発現させるプラスミド
US5807702A (en) * 1995-02-27 1998-09-15 Abbott Laboratories Method for expressing phosphorylated recombinant human β-casein in a bacterial system
EP0862450A2 (de) * 1995-11-06 1998-09-09 Abbott Laboratories Verfahren zur hemmung der anheftung von h.influenzae an menschlichen zellen unter verwendung von phosphoryliertem recombinant menschlichen beta-casein

Also Published As

Publication number Publication date
MX9803568A (es) 1998-09-30
JP2000503319A (ja) 2000-03-21
CA2234680A1 (en) 1997-07-24
EP0859629A2 (de) 1998-08-26
EP0859629B1 (de) 2003-08-13
DE69629487D1 (de) 2003-09-18
WO1997026320A2 (en) 1997-07-24
AU1158197A (en) 1997-08-11
WO1997026320A3 (en) 1997-09-12

Similar Documents

Publication Publication Date Title
Mameesh et al. Production of dietary vit. K deficiency in the rat.
ATE84967T1 (de) Verwendung von pentoxifyllin zur behandlung entzuendlicher erkrankungen.
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
AU1943388A (en) 3-indolepyruvic acid derivatives and pharmaceutical use thereof
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
EP0250994A3 (en) Product for covering healthy or damaged areas of the human or animal skin
MY115211A (en) Novel amino acid derivatives, their preparation and use
ATE35415T1 (de) Pharmazeutische zusammensetzungen und verfahren fuer die herstellung von zusammensetzungen mit gehalt an phosphatidylserine zur behandlung von stoerungen des centralen nervensystems ohne wirkungen auf die blutkoagulation.
ATE123944T1 (de) Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen.
HU911184D0 (en) Process for the production of medical preparations containing n-alkylized 1,4-dihydropirine-carbonic acid esthers and process for the production of such esthers
ATE145554T1 (de) Verwendung von kurzkettige fettsäuren enthaltenden lipiden zur aufrechterhaltung der integrität und der funktion des magen-darm-kanals
MX9803565A (es) Metodo para inhibir la union de h, influenzae a celulas humanas utilizando beta-caseina humana, fosforilada, recombinante.
DE69629487D1 (de) Phosphoryliertes rekombinantes menschliches beta-kasein für die hemmung der anheftung von h. influenzae an menschlichen zellen
ES8707111A1 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
HUT49284A (en) Process for production of medical compositions applicable "in loco" against androgene hairlessness
FI895765A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten lysogangliosidijohdannaisten valmistamiseksi
HUP9800964A2 (hu) O- és S-tartalmú 6 tagú benzo-kondenzált heterociklusos vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
MX9605829A (es) Inhibicion de la union del h. influenzae a celulas humanas.
JPS6455143A (en) Production of milk powder for nursing which is endowed with phylactic ability
NZ329311A (en) use of beta-casein to inhibit infection in mammalian cells by respiratory syncytial virus
ES8300475A1 (es) Un procedimiento para la preparacion de un alergeno
Holborow Sudden infant death syndrome
ATE40795T1 (de) Verwendung eines zerebral und peripher wirkenden antihypoxidotikums.
GR3001209T3 (en) 4-methoxy-isophthalic acid derivative having a pharmacological activity in thromboembolic disorders and a process for the preparation thereof
MX9605830A (es) Inhibicion de la infeccion de las celulas de mamiferos por el virus sincicial respiratorio.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties